Submission Details
| 510(k) Number | K012312 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | July 23, 2001 |
| Decision Date | August 20, 2001 |
| Days to Decision | 28 days |
| Submission Type | Traditional |
| Review Panel | Toxicology (TX) |
| Summary | Summary PDF |
K012312 is an FDA 510(k) clearance for the IMMULITE 2000 TOBRAMYCN, MODELS L2KTC2 (2002 TESTS), L2KTC6 (600 TESTS), a Radioimmunoassay, Tobramycin (Class II — Special Controls, product code KLB), submitted by Diagnostic Products Corp. (Los Angeles, US). The FDA issued a Cleared decision on August 20, 2001, 28 days after receiving the submission on July 23, 2001. This device falls under the Toxicology review panel. Regulated under 21 CFR 862.3900.
| 510(k) Number | K012312 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | July 23, 2001 |
| Decision Date | August 20, 2001 |
| Days to Decision | 28 days |
| Submission Type | Traditional |
| Review Panel | Toxicology (TX) |
| Summary | Summary PDF |
| Product Code | KLB — Radioimmunoassay, Tobramycin |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.3900 |